Scaling Psilocybin Therapy: Compass Pathways' Lars Wilde

Business Trip - A podcast by Greg Kubin & Matias Serebrinsky - Thursdays

Episode 10 features Lars Wilde, co-founder and Chief Business Officer of Compass Pathways, a mental health company with an initial focus on psilocybin therapy for Treatment-Resistant Depression. In this episode, we discuss: Lars’ experience overcoming Treatment-Resistant Depression with psilocybinThe nuances of clinical trials and psilocybin dosing protocolsCompass Pathways’ Intellectual Property strategyWhat additional indications and therapies Compass Pathways is interested in Links to top...

Visit the podcast's native language site